Active Surveillance for Intermediate-risk Prostate Cancer Challenged July 18, 2017 New study findings suggest there is no “favorable” subset of patients with intermediate-risk prostate cancer (PCa) likely to benefit from active surveillance.Read more.Source: Renal and Urology News Prostate Cancer News
New study findings suggest there is no “favorable” subset of patients with intermediate-risk prostate cancer (PCa) likely to benefit from active surveillance.Read more.Source: Renal and Urology News
